Nobel Biocare expands digital dentistry portfolio with DEXIS Imprevo scanner

Kloten, Switzerland – December 22, 2025 – Nobel Biocare has announced the addition of the DEXIS Imprevo intraoral scanner to its digital dentistry portfolio. This strategic move reinforces Nobel Biocare’s commitment to delivering best-in-class digital solutions and clinical excellence to dental professionals worldwide. 

Expanded digital portfolio 
By integrating the DEXIS Imprevo scanner into its distribution network, Nobel Biocare enhances its digital ecosystem, offering clinicians a seamless end-to-end workflow from scan to final restoration.   

The Imprevo scanner sets a new benchmark in speed, precision, and wireless freedom. Its advanced parallel processing, vivid color rendering, and direct integration with DTX Studio™ Clinic enable optimal patient communication and treatment planning. Features that set this new scanner apart include: 

Slimmer design: 20% slimmer than the IS 3800 family, enhancing comfort for both clinician and patient. 
Improved speed: Maximum 40 frames per second (FPS), double that of IS 3800 scanners. 
Extended Depth of Field (DOF): 25 mm (-2 to +23 mm), a 39% increase over the IS 3800 series, facilitating scanning of deeper preparations and interdental spaces. 
– Parallel processing: Leverages GPU-based parallel processing technology for detailed, refined meshes, higher data density, and faster processing.   

Strategic synergy 
Nobel Biocare and DEXIS share a vision for advancing dental innovation. This collaboration combines cutting-edge scanning technology with Nobel Biocare’s precision solutions in restorative and implant dentistry, empowering clinicians to deliver exceptional patient outcomes.  

"We are excited to welcome the DEXIS Imprevo scanner to our digital portfolio,” said Rosemary O’Neill, Vice President Procera and Digital Solutions . “This addition underscores our dedication to providing diverse, high-quality solutions that meet the evolving needs of our customers.” 

Nobel Biocare and DEXIS are both part of Envista Holdings Corporation, a global family of more than 30 trusted dental brands united by a shared purpose: partnering with professionals to improve lives.   For more information about the DEXIS Imprevo scanner distributed by Nobel Biocare, visit www.nobelbiocare.com/en-int/dexis-intraoral-scanner.

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including Nobel Biocare N1™, NobelActive®, NobelParallel™, and the All-on-4® treatment concept), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), prefabricated prosthetics, and a wide variety of regenerative solutions (creos™). Products are supported by a single digital platform for imaging, diagnostics, and treatment planning (DTX Studio™ suite), and guided and navigated surgery (NobelGuide® and X-Guide®). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland, and production takes place at sites located in the United States and Sweden. Products and services are available in over 50 countries through subsidiaries and distributors. Nobel Biocare is part the Envista family, one of the largest global dental products companies with more than 30 trusted dental brands. For more information, please visit https://www.nobelbiocare.com.

Related articles